These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
336 related articles for article (PubMed ID: 31148358)
1. A novel method for evaluating and quantifying cell types in platelet rich fibrin and an introduction to horizontal centrifugation. Miron RJ; Chai J; Zheng S; Feng M; Sculean A; Zhang Y J Biomed Mater Res A; 2019 Oct; 107(10):2257-2271. PubMed ID: 31148358 [TBL] [Abstract][Full Text] [Related]
2. A novel method for harvesting concentrated platelet-rich fibrin (C-PRF) with a 10-fold increase in platelet and leukocyte yields. Miron RJ; Chai J; Zhang P; Li Y; Wang Y; Mourão CFAB; Sculean A; Fujioka Kobayashi M; Zhang Y Clin Oral Investig; 2020 Aug; 24(8):2819-2828. PubMed ID: 31788748 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of 24 protocols for the production of platelet-rich fibrin. Miron RJ; Chai J; Fujioka-Kobayashi M; Sculean A; Zhang Y BMC Oral Health; 2020 Nov; 20(1):310. PubMed ID: 33160335 [TBL] [Abstract][Full Text] [Related]
4. The impact of the centrifuge characteristics and centrifugation protocols on the cells, growth factors, and fibrin architecture of a leukocyte- and platelet-rich fibrin (L-PRF) clot and membrane. Dohan Ehrenfest DM; Pinto NR; Pereda A; Jiménez P; Corso MD; Kang BS; Nally M; Lanata N; Wang HL; Quirynen M Platelets; 2018 Mar; 29(2):171-184. PubMed ID: 28437133 [TBL] [Abstract][Full Text] [Related]
5. Histological comparison of Platelet rich fibrin clots prepared by fixed-angle versus horizontal centrifugation. Fujioka-Kobayashi M; Kono M; Katagiri H; Schaller B; Zhang Y; Sculean A; Miron RJ Platelets; 2021 Apr; 32(3):413-419. PubMed ID: 32306811 [TBL] [Abstract][Full Text] [Related]
6. Improved growth factor delivery and cellular activity using concentrated platelet-rich fibrin (C-PRF) when compared with traditional injectable (i-PRF) protocols. Fujioka-Kobayashi M; Katagiri H; Kono M; Schaller B; Zhang Y; Sculean A; Miron RJ Clin Oral Investig; 2020 Dec; 24(12):4373-4383. PubMed ID: 32382929 [TBL] [Abstract][Full Text] [Related]
7. Comparison of platelet-rich fibrin (PRF) produced using 3 commercially available centrifuges at both high (~ 700 g) and low (~ 200 g) relative centrifugation forces. Miron RJ; Xu H; Chai J; Wang J; Zheng S; Feng M; Zhang X; Wei Y; Chen Y; Mourão CFAB; Sculean A; Zhang Y Clin Oral Investig; 2020 Mar; 24(3):1171-1182. PubMed ID: 31321574 [TBL] [Abstract][Full Text] [Related]
8. Effects of platelet-rich fibrin produced by three centrifugation protocols on bone neoformation in defects created in rat calvaria. Ferreira Sávio DS; Silva LMPD; Reis GGD; Denardi RJ; Costa NMMD; Chaves Furlaneto FA; Souza SLS; Mourão CFAB; Miron RJ; Okamoto R; Messora MR Platelets; 2023 Dec; 34(1):2228417. PubMed ID: 37409489 [TBL] [Abstract][Full Text] [Related]
9. Reduction of relative centrifugation force within injectable platelet-rich-fibrin (PRF) concentrates advances patients' own inflammatory cells, platelets and growth factors: the first introduction to the low speed centrifugation concept. Choukroun J; Ghanaati S Eur J Trauma Emerg Surg; 2018 Feb; 44(1):87-95. PubMed ID: 28283682 [TBL] [Abstract][Full Text] [Related]
10. A Standardized Al-Maawi S; Dohle E; Kretschmer W; Rutkowski J; Sader R; Ghanaati S Tissue Eng Part A; 2022 Apr; 28(7-8):353-365. PubMed ID: 34555949 [TBL] [Abstract][Full Text] [Related]
11. Effect of relative centrifugal force on the biological properties of liquid platelet-rich fibrin produced via horizontal centrifugation. Feng M; Wei Y; Wei H; Wang Y; Zhang Y; Miron RJ; Wang Y Clin Oral Investig; 2023 Jan; 27(1):399-409. PubMed ID: 36242639 [TBL] [Abstract][Full Text] [Related]
12. Impact of different platelet-rich fibrin (PRF) procurement methods on the platelet count, antimicrobial efficacy, and fibrin network pattern in different age groups: an in vitro study. Mamajiwala AS; Sethi KS; Raut CP; Karde PA; Mangle NM Clin Oral Investig; 2020 May; 24(5):1663-1675. PubMed ID: 31346783 [TBL] [Abstract][Full Text] [Related]
13. Extending the working properties of liquid platelet-rich fibrin using chemically modified PET tubes and the Bio-Cool device. Miron RJ; Horrocks NA; Zhang Y; Horrocks G; Pikos MA; Sculean A Clin Oral Investig; 2022 Mar; 26(3):2873-2878. PubMed ID: 34816309 [TBL] [Abstract][Full Text] [Related]
14. Reduction of the relative centrifugal force influences cell number and growth factor release within injectable PRF-based matrices. Wend S; Kubesch A; Orlowska A; Al-Maawi S; Zender N; Dias A; Miron RJ; Sader R; Booms P; Kirkpatrick CJ; Choukroun J; Ghanaati S J Mater Sci Mater Med; 2017 Oct; 28(12):188. PubMed ID: 29071440 [TBL] [Abstract][Full Text] [Related]
15. Relative Centrifugal Force (RCF; Kargarpour Z; Nasirzade J; Panahipour L; Miron RJ; Gruber R Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33076376 [TBL] [Abstract][Full Text] [Related]
16. Advances in separation methods for the use of platelet-rich fibrin in tissue repair: an integrative review. Dos Santos RF; Araújo Peres JA; Queiroz MS Gen Dent; 2023; 71(2):65-69. PubMed ID: 36825976 [TBL] [Abstract][Full Text] [Related]
17. Advanced platelet-rich fibrin: a new concept for cell-based tissue engineering by means of inflammatory cells. Ghanaati S; Booms P; Orlowska A; Kubesch A; Lorenz J; Rutkowski J; Landes C; Sader R; Kirkpatrick C; Choukroun J J Oral Implantol; 2014 Dec; 40(6):679-89. PubMed ID: 24945603 [TBL] [Abstract][Full Text] [Related]
19. Influence of haematological parameters on size of the advanced platelet-rich fibrin+ (A-PRF+) in the horse. Chiara M; Mariaelena C; Alessandro C; Davide B; Lavinia C; Paola MM; Barbara L; Chiara DP; Flagiello F; Pia PM Res Vet Sci; 2024 Sep; 177():105367. PubMed ID: 39098093 [TBL] [Abstract][Full Text] [Related]
20. Impact of g force and timing on the characteristics of platelet-rich fibrin matrices. Castro AB; Andrade C; Li X; Pinto N; Teughels W; Quirynen M Sci Rep; 2021 Mar; 11(1):6038. PubMed ID: 33727689 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]